September 2023 PMID 37650489

Psilocybin history, action and reaction: A narrative clinical review.

Pravesh Sharma, Quang Anh Nguyen, Sadie J Matthews, Erin Carpenter, Douglas B Mathews, Christi A Patten, Christopher J Hammond

Mentions

6
Peak: 2 in Aug 2023
across 2 sources since Aug 2023

Extended reach

14,832
potential audience

Total likes

27

Video views

933

Mentions per month

Aug 2023 – Mar 2025

Where it's discussed

  • X / Twitter4 posts
  • YouTube2 videos

AI synopsis

What people are saying

The overall tone indicates a positive reception, with mentions of the article providing a 'comprehensive review' and noting the potential of psilocybin for treating mood disorders, which reflects the users' recognition of its significance. Words like 'valuable' and 'informative' convey interest, while references to legal developments and medical implications suggest a moderate potential for influence.

AgreementModerate agreement

Most posts appear to agree with the publication, recognizing its value in providing a comprehensive overview of psilocybin's history and potential therapeutic benefits.

InterestHigh interest

Users show high interest, citing the article as informative and relevant to emerging treatments and cultural history.

EngagementModerate engagement

Posts demonstrate moderate engagement, with some reflecting on implications and applications, though few delve deeply into analysis.

ImpactModerate impact

The discussions hint at a moderate impact, highlighting the importance of understanding psilocybin's role in current medical and legal contexts.

Abstract in brief

  • Psilocybin, a psychoactive compound found in hallucinogenic mushrooms, has been used for centuries in religious and cultural practices and is now gaining attention as a potential treatment for mood and substance use disorders.
  • Clinical evidence suggests that psilocybin-assisted therapy may help reduce depression, anxiety, and harmful drinking, with mild and transient side effects; however, serious adverse events are rare but require further investigation.
  • As some US states legalize psilocybin for medical and recreational use, healthcare providers need to understand its benefits and risks to advise patients accurately, with ongoing research needed to identify the best candidates for this therapy.]

Top posts

Most liked on X and Bluesky
Amsterdam Psychedelic Research Association (APRA)
@APRAresearch · X

Psilocybin history, action and reaction: A narrative clinical review https://t.co/8L9vnE1a85

Aug 31, 2023 · 4 likes · 2 shares · 3,999 followers View post →
THERADELICS
@theradelics · X

Psilocybin history, action and reaction: A narrative clinical review https://t.co/VJYbmqEYv6 https://t.co/nqMNQaEnpP

Sep 1, 2023 · 1 like · 3,383 followers View post →
Mind Escape Podcast
@MikeEscape · X

RT @APRAresearch: Psilocybin history, action and reaction: A narrative clinical review https://t.co/8L9vnE1a85

Aug 31, 2023 · 2 shares · 4,081 followers View post →
Sebation Thomas
@SupremeFireCPG · X

RT @APRAresearch: Psilocybin history, action and reaction: A narrative clinical review https://t.co/8L9vnE1a85

Sep 1, 2023 · 2 shares · 2,425 followers View post →

All mentions

THERADELICS
@theradelics · X

Psilocybin history, action and reaction: A narrative clinical review https://t.co/VJYbmqEYv6 https://t.co/nqMNQaEnpP

Sep 1, 2023 · 1 like · 3,383 followers View post →
Sebation Thomas
@SupremeFireCPG · X

RT @APRAresearch: Psilocybin history, action and reaction: A narrative clinical review https://t.co/8L9vnE1a85

Sep 1, 2023 · 2 shares · 2,425 followers View post →
Mind Escape Podcast
@MikeEscape · X

RT @APRAresearch: Psilocybin history, action and reaction: A narrative clinical review https://t.co/8L9vnE1a85

Aug 31, 2023 · 2 shares · 4,081 followers View post →
Amsterdam Psychedelic Research Association (APRA)
@APRAresearch · X

Psilocybin history, action and reaction: A narrative clinical review https://t.co/8L9vnE1a85

Aug 31, 2023 · 4 likes · 2 shares · 3,999 followers View post →